ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Coenzyme Q10 for Gulf War Illness: A Replication Study

ClinicalTrials.gov ID: NCT06515184

Public ClinicalTrials.gov record NCT06515184. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06515184
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of California, San Diego
Other
Enrollment
192 participants

Conditions and interventions

Interventions

  • PharmaNord Bio-Quinone Active CoQ10 Gold 100mg Drug
  • PharmaNord Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 12, 2024
Primary completion
Nov 30, 2027
Completion
Nov 30, 2027
Last update posted
Apr 30, 2026

2024 – 2027

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
UC San Diego La Jolla California 92093 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06515184, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06515184 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →